MEI Pharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2022 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
MEI Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q1 2024.
- MEI Pharma, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $702K, a 26.3% decline year-over-year.
- MEI Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $3.71M.
- MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $4.93M, a 76.6% decline from 2022.
- MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $21M, a 10% increase from 2021.
- MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $19.1M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)